Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis

Description

This pilot study will randomize 40 female patients with acute uncomplicated pyelonephritis to receive standard duration of therapy versus patient-directed antimicrobial duration (PDAD). The primary objectives of this pilot trial are to determine the feasibility and safety of conducting a full-scale multi-center randomized controlled trial.

Conditions

Pyelonephritis Acute

Study Overview

Study Details

Study overview

This pilot study will randomize 40 female patients with acute uncomplicated pyelonephritis to receive standard duration of therapy versus patient-directed antimicrobial duration (PDAD). The primary objectives of this pilot trial are to determine the feasibility and safety of conducting a full-scale multi-center randomized controlled trial.

Personalized Antibiotic Treatment in the Emergency Department: Panther Trial

Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis

Condition
Pyelonephritis Acute
Intervention / Treatment

-

Contacts and Locations

Sylmar

Olive View - UCLA Medical Center, Sylmar, California, United States, 91342

Iowa City

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States, 52242

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 55 Years

    Sexes Eligible for Study

    FEMALE

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Brett A Faine,

    Study Record Dates

    2025-01-31